Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study-Reference-Cited by-同舟云学术

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

Published:2019-02-01 Issue:6 Volume:104 Page:2367-2374
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Hescot Segolene¹^ORCID,Curras-Freixes Maria²,Deutschbein Timo³,van Berkel Anouk⁴,Vezzosi Delphine⁵,Amar Laurence⁶⁷,de la Fouchardière Christelle⁸,Valdes Nuria⁹¹⁰,Riccardi Fernando¹¹,Do Cao Christine¹²,Bertherat Jerome¹³,Goichot Bernard¹⁴,Beuschlein Felix¹⁵¹⁶,Drui Delphine¹⁷,Canu Letizia¹⁸,Niccoli Patricia¹⁹,Laboureau Sandrine²⁰,Tabarin Antoine²¹,Leboulleux Sophie¹,Calsina Bruna²,Libé Rossella¹³,Faggiano Antongiulio²²,Schlumberger Martin¹,Borson-Chazot Francoise⁸,Mannelli Massimo¹⁸,Gimenez-Roqueplo Anne-Paule⁶⁷,Caron Philippe⁵,Timmers Henri J L M⁴,Fassnacht Martin³,Robledo Mercedes²,Borget Isabelle²³²⁴,Baudin Eric¹,

Affiliation:

1. Department of Nuclear Medicine and Endocrine Tumors, Gustave Roussy, Villejuif, France

2. Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

3. Department of Internal Medicine and Central Laboratory, University Hospital of Würzburg, Würzburg, Germany

4. Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands

5. Department of Endocrinology, CHU Toulouse, Toulouse, France

6. Department of Genetics, Hôpital Européen Georges Pompidou, Paris, France

7. INSERM UMR970, Paris-Cardiovascular Research Center, Paris Descartes University, Paris, France

8. Hospices Civils de Lyon and Centre Léon Bérard, University Lyon I, Lyon, France

9. Department of Endocrinology and Nutrition, University Hospital Central de Asturias, Oviedo, Spain

10. Unit of Endocrinology, Nutrition, Diabetes and Obesity, Institute of Sanitary Research of Asturias, Oviedo, Spain

11. Azienda Ospedaliera Antonio Cardarelli, Naples, Italy

12. Department of Endocrinology, Hôpital Huriez, CHR-U, Lille, France

13. Department of Endocrinology, Hôpital Cochin, Paris, France

14. Department of Internal Medicine, Endocrinology and Nutrition, University Hospital of Strasbourg, Strasbourg, France

15. Medical Clinics and Polyclinics IV, University Hospital of Munich, Munich, Germany

16. Unit of Endocrinology, Nutrition, Diabetes, University Hospital of Zurich, Zurich, Switzerland

17. Department of Endocrinology, L’Institut du Thorax, CHU Nantes, Nantes, France

18. Department of Experimental and Clinical Biomedical Sciences, “Mario Serio,” University of Florence, Florence, Italy

19. Department of Oncology, Institut Paoli Calmettes, Marseille, France

20. Department of Endocrinology, CHU Angers, Angers, France

21. Department of Endocrinology, CHU Bordeaux, Bordeaux, France

22. Division of Endocrinology, Department of Clinical Medicine and Surgery, Università Federico II, Naples, Italy

23. Department of Biostatistic and Epidemiology, Gustave Roussy, Villejuif, France

24. University Paris-Saclay, University Paris-Sud, UVSQ, CESP ONCOSTAT, INSERM, Villejuif, France

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/104/6/2367/28561029/jc.2018-01968.pdf

Reference25 articles.

1. Phaeochromocytoma;Lenders;Lancet,2005

2. The diagnosis and management of malignant phaeochromocytoma and paraganglioma;Chrisoulidou;Endocr Relat Cancer,2007

3. Genetic testing in pheochromocytoma or functional paraganglioma;Amar;J Clin Oncol,2005

4. One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma;Hescot;J Clin Endocrinol Metab,2013

5. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas;Amar;J Clin Endocrinol Metab,2007

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice;Molecular and Cellular Endocrinology;2024-10

2. Molecular genetics of pheochromocytoma/paraganglioma;Current Opinion in Endocrine and Metabolic Research;2024-09

3. Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients;Frontiers in Endocrinology;2024-08-21

4. Management of metastatic pheochromocytomas and paragangliomas: when and what;Current Problems in Cancer;2024-08

5. Personalized management for phaeochromocytomas and paragangliomas in Latin America: A genetic perspective;Best Practice & Research Clinical Endocrinology & Metabolism;2024-08